Evaluating the Emerging Clinical Benefit of OCT Angiography in Practice
This supplement, sponsored by Zeiss, was published at the 17th EURETINA Congress in Barcelona, Spain, in association with ET Today, the daily congress newspaper produced by EuroTimes.
In the supplement, key opinion leaders discuss how Ocular Coherence Tomography Angiography (OCTA) can help surgeons improve their diagnosis and treatment of retinal disease.
OCTA Promising For Identifying Vascular Changes Earlier in Diabetic Patients
Prof Sebastian Wolf
Emergency Clinical Value Of OCTA
Prof Pravin A. Dugel
Adding OCTA To Your Practice
Prof Frank G. Holz
Download Supplement - click here
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.